Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Professional Survey Report 2018

January 2018 | 123 pages | ID: G00C71101F8EN
QYResearch

Abstracts

This report studies Ventilator Associated Pneumonia (VAP) Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Achaogen Inc
• Adenium Biotech ApS
• Aridis Pharmaceuticals LLC
• AstraZeneca Plc
• Bayer AG
• Cardeas Pharma Corp
• Destiny Pharma Ltd
• Dong-A Socio Holdings Co Ltd
• Lakewood-Amedex Inc
• MedImmune LLC
• Meiji Seika Pharma Co Ltd
• Merck & Co Inc
• Motif Bio Plc
• Nabriva Therapeutics AG
• Polyphor Ltd
• Shionogi & Co Ltd
• Tetraphase Pharmaceuticals Inc
• The Medicines Company
• Theravance Biopharma Inc
• Wockhardt Ltd
• Zavante Therapeutics Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Prevention
• Physiotherapy
• Immunity Therapy

By Application, the market can be split into

• Hospitals
• Ambulatory Surgical Center
• Diagnostic Centers

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS

1.1 Definition and Specifications of Ventilator Associated Pneumonia (VAP) Therapeutics
  1.1.1 Definition of Ventilator Associated Pneumonia (VAP) Therapeutics
  1.1.2 Specifications of Ventilator Associated Pneumonia (VAP) Therapeutics
1.2 Classification of Ventilator Associated Pneumonia (VAP) Therapeutics
  1.2.1 Prevention
  1.2.2 Physiotherapy
  1.2.3 Immunity Therapy
1.3 Applications of Ventilator Associated Pneumonia (VAP) Therapeutics
  1.3.1 Hospitals
  1.3.2 Ambulatory Surgical Center
  1.3.3 Diagnostic Centers
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ventilator Associated Pneumonia (VAP) Therapeutics
2.3 Manufacturing Process Analysis of Ventilator Associated Pneumonia (VAP) Therapeutics
2.4 Industry Chain Structure of Ventilator Associated Pneumonia (VAP) Therapeutics

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS

3.1 Capacity and Commercial Production Date of Global Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016

4 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Ventilator Associated Pneumonia (VAP) Therapeutics Capacity and Growth Rate Analysis
  4.2.2 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Growth Rate Analysis
  4.3.2 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price
  4.4.2 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price Analysis (Company Segment)

5 VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS REGIONAL MARKET ANALYSIS

5.1 North America Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis
  5.1.1 North America Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview
  5.1.2 North America 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price Analysis
  5.1.4 North America 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Market Share Analysis
5.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis
  5.2.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview
  5.2.2 China 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price Analysis
  5.2.4 China 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Market Share Analysis
5.3 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis
  5.3.1 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview
  5.3.2 Europe 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price Analysis
  5.3.4 Europe 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Market Share Analysis
5.4 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis
  5.4.1 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview
  5.4.2 Southeast Asia 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price Analysis
  5.4.4 Southeast Asia 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Market Share Analysis
5.5 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis
  5.5.1 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview
  5.5.2 Japan 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price Analysis
  5.5.4 Japan 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Market Share Analysis
5.6 India Ventilator Associated Pneumonia (VAP) Therapeutics Market Analysis
  5.6.1 India Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview
  5.6.2 India 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price Analysis
  5.6.4 India 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Market Share Analysis

6 GLOBAL 2012-2017E VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales by Type
6.2 Different Types of Ventilator Associated Pneumonia (VAP) Therapeutics Product Interview Price Analysis
6.3 Different Types of Ventilator Associated Pneumonia (VAP) Therapeutics Product Driving Factors Analysis
  6.3.1 Prevention of Ventilator Associated Pneumonia (VAP) Therapeutics Growth Driving Factor Analysis
  6.3.2 Physiotherapy of Ventilator Associated Pneumonia (VAP) Therapeutics Growth Driving Factor Analysis
  6.3.3 Immunity Therapy of Ventilator Associated Pneumonia (VAP) Therapeutics Growth Driving Factor Analysis

7 GLOBAL 2012-2017E VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Consumption by Application
7.2 Different Application of Ventilator Associated Pneumonia (VAP) Therapeutics Product Interview Price Analysis
7.3 Different Application of Ventilator Associated Pneumonia (VAP) Therapeutics Product Driving Factors Analysis
  7.3.1 Hospitals of Ventilator Associated Pneumonia (VAP) Therapeutics Growth Driving Factor Analysis
  7.3.2 Ambulatory Surgical Center of Ventilator Associated Pneumonia (VAP) Therapeutics Growth Driving Factor Analysis
  7.3.3 Diagnostic Centers of Ventilator Associated Pneumonia (VAP) Therapeutics Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS

8.1 Achaogen Inc
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Achaogen Inc 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Achaogen Inc 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.2 Adenium Biotech ApS
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Adenium Biotech ApS 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Adenium Biotech ApS 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.3 Aridis Pharmaceuticals LLC
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Aridis Pharmaceuticals LLC 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Aridis Pharmaceuticals LLC 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.4 AstraZeneca Plc
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 AstraZeneca Plc 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 AstraZeneca Plc 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.5 Bayer AG
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Bayer AG 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Bayer AG 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.6 Cardeas Pharma Corp
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Cardeas Pharma Corp 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Cardeas Pharma Corp 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.7 Destiny Pharma Ltd
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Destiny Pharma Ltd 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Destiny Pharma Ltd 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.8 Dong-A Socio Holdings Co Ltd
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Dong-A Socio Holdings Co Ltd 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Dong-A Socio Holdings Co Ltd 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.9 Lakewood-Amedex Inc
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Lakewood-Amedex Inc 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Lakewood-Amedex Inc 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.10 MedImmune LLC
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 MedImmune LLC 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 MedImmune LLC 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution Analysis
8.11 Meiji Seika Pharma Co Ltd
8.12 Merck & Co Inc
8.13 Motif Bio Plc
8.14 Nabriva Therapeutics AG
8.15 Polyphor Ltd
8.16 Shionogi & Co Ltd
8.17 Tetraphase Pharmaceuticals Inc
8.18 The Medicines Company
8.19 Theravance Biopharma Inc
8.20 Wockhardt Ltd
8.21 Zavante Therapeutics Inc

9 DEVELOPMENT TREND OF ANALYSIS OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET

9.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Trend Analysis
  9.1.1 Global 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price Forecast
9.2 Ventilator Associated Pneumonia (VAP) Therapeutics Regional Market Trend
  9.2.1 North America 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Forecast
  9.2.2 China 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Forecast
  9.2.3 Europe 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Forecast
  9.2.5 Japan 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Forecast
  9.2.6 India 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Forecast
9.3 Ventilator Associated Pneumonia (VAP) Therapeutics Market Trend (Product Type)
9.4 Ventilator Associated Pneumonia (VAP) Therapeutics Market Trend (Application)

10 VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKETING TYPE ANALYSIS

10.1 Ventilator Associated Pneumonia (VAP) Therapeutics Regional Marketing Type Analysis
10.2 Ventilator Associated Pneumonia (VAP) Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Ventilator Associated Pneumonia (VAP) Therapeutics by Region
10.4 Ventilator Associated Pneumonia (VAP) Therapeutics Supply Chain Analysis

11 CONSUMERS ANALYSIS OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP) THERAPEUTICS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ventilator Associated Pneumonia (VAP) Therapeutics
Table Product Specifications of Ventilator Associated Pneumonia (VAP) Therapeutics
Table Classification of Ventilator Associated Pneumonia (VAP) Therapeutics
Figure Global Production Market Share of Ventilator Associated Pneumonia (VAP) Therapeutics by Type in 2016
Figure Prevention Picture
Table Major Manufacturers of Prevention
Figure Physiotherapy Picture
Table Major Manufacturers of Physiotherapy
Figure Immunity Therapy Picture
Table Major Manufacturers of Immunity Therapy
Table Applications of Ventilator Associated Pneumonia (VAP) Therapeutics
Figure Global Consumption Volume Market Share of Ventilator Associated Pneumonia (VAP) Therapeutics by Application in 2016
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Ambulatory Surgical Center Examples
Table Major Consumers in Ambulatory Surgical Center
Figure Diagnostic Centers Examples
Table Major Consumers in Diagnostic Centers
Figure Market Share of Ventilator Associated Pneumonia (VAP) Therapeutics by Regions
Figure North America Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Million USD) (2012-2022)
Figure China Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Million USD) (2012-2022)
Figure India Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Million USD) (2012-2022)
Table Ventilator Associated Pneumonia (VAP) Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ventilator Associated Pneumonia (VAP) Therapeutics in 2016
Figure Manufacturing Process Analysis of Ventilator Associated Pneumonia (VAP) Therapeutics
Figure Industry Chain Structure of Ventilator Associated Pneumonia (VAP) Therapeutics
Table Capacity and Commercial Production Date of Global Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Ventilator Associated Pneumonia (VAP) Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Ventilator Associated Pneumonia (VAP) Therapeutics 2012-2017
Figure Global 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Ventilator Associated Pneumonia (VAP) Therapeutics Capacity and Growth Rate
Table 2016 Global Ventilator Associated Pneumonia (VAP) Therapeutics Capacity (Units) List (Company Segment)
Table 2012-2017E Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) and Growth Rate
Table 2016 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) List (Company Segment)
Table 2012-2017E Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit)
Table 2016 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (Units) of Ventilator Associated Pneumonia (VAP) Therapeutics 2012-2017E
Figure North America 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit)
Figure North America 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (Units) of Ventilator Associated Pneumonia (VAP) Therapeutics 2012-2017E
Figure China 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit)
Figure China 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (Units) of Ventilator Associated Pneumonia (VAP) Therapeutics 2012-2017E
Figure Europe 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit)
Figure Europe 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (Units) of Ventilator Associated Pneumonia (VAP) Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit)
Figure Southeast Asia 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (Units) of Ventilator Associated Pneumonia (VAP) Therapeutics 2012-2017E
Figure Japan 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit)
Figure Japan 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (Units) of Ventilator Associated Pneumonia (VAP) Therapeutics 2012-2017E
Figure India 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit)
Figure India 2016 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share
Table Global 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) by Type
Table Different Types Ventilator Associated Pneumonia (VAP) Therapeutics Product Interview Price
Table Global 2012-2017E Ventilator Associated Pneumonia (VAP) Therapeutics Sales (Units) by Application
Table Different Application Ventilator Associated Pneumonia (VAP) Therapeutics Product Interview Price
Table Achaogen Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table Adenium Biotech ApS Information List
Table Product A Overview
Table Product B Overview
Table 2016 Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table Aridis Pharmaceuticals LLC Information List
Table Product A Overview
Table Product B Overview
Table 2015 Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table AstraZeneca Plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table Bayer AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table Cardeas Pharma Corp Information List
Table Product A Overview
Table Product B Overview
Table 2016 Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table Destiny Pharma Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2016 Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table Dong-A Socio Holdings Co Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table Lakewood-Amedex Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table MedImmune LLC Information List
Table Product A Overview
Table Product B Overview
Table 2016 MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Business Region Distribution
Table Meiji Seika Pharma Co Ltd Information List
Table Merck & Co Inc Information List
Table Motif Bio Plc Information List
Table Nabriva Therapeutics AG Information List
Table Polyphor Ltd Information List
Table Shionogi & Co Ltd Information List
Table Tetraphase Pharmaceuticals Inc Information List
Table The Medicines Company Information List
Table Theravance Biopharma Inc Information List
Table Wockhardt Ltd Information List
Table Zavante Therapeutics Inc Information List
Figure Global 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Units) and Growth Rate Forecast
Figure Global 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Sales Price (K USD/Unit) Forecast
Figure North America 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Volume (Units) and Growth Rate Forecast
Figure China 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Volume (Units) and Growth Rate Forecast
Figure Europe 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Volume (Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Volume (Units) and Growth Rate Forecast
Figure Japan 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Volume (Units) and Growth Rate Forecast
Figure India 2017-2022 Ventilator Associated Pneumonia (VAP) Therapeutics Consumption Volume (Units) and Growth Rate Forecast
Table Global Sales Volume (Units) of Ventilator Associated Pneumonia (VAP) Therapeutics by Type 2017-2022
Table Global Consumption Volume (Units) of Ventilator Associated Pneumonia (VAP) Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Ventilator Associated Pneumonia (VAP) Therapeutics by Region